Literature DB >> 26015423

Is It Beneficial to Convert to a Neutral-pH Bicarbonate/Lactate-Buffered PD Solution in Long-Term CAPD Patients? A Single-Center Prospective Study.

Tae-Hyun Yoo1, Mi Jung Lee1, Hyung Jung Oh1, Jung Tak Park1, Seung Hyeok Han1, Shin-Wook Kang1, Dae Suk Han2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26015423      PMCID： PMC4443999          DOI： 10.3747/pdi.2013.00284

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  15 in total

1.  Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.

Authors:  Ole Simonsen; Gunnar Sterner; Ola Carlsson; Anders Wieslander; Bengt Rippe
Journal:  Perit Dial Int       Date:  2006 May-Jun       Impact factor: 1.756

2.  Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.

Authors:  K N Lai; K B Lai; C W Lam; T M Chan; F K Li; J C Leung
Journal:  Am J Kidney Dis       Date:  2000-04       Impact factor: 8.860

3.  Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.

Authors:  S Jones; C J Holmes; R T Krediet; R Mackenzie; D Faict; A Tranaeus; J D Williams; G A Coles; N Topley
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

4.  Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.

Authors:  Siska Mortier; Dirk Faict; Norbert H Lameire; An S De Vriese
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

5.  Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

Authors:  Siska Mortier; Dirk Faict; Casper G Schalkwijk; Norbert H Lameire; An S De Vriese
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

6.  Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.

Authors:  Seung Hyeok Han; Song Vogue Ahn; Jee Young Yun; Anders Tranaeus; Dae-Suk Han
Journal:  Am J Kidney Dis       Date:  2009-07-19       Impact factor: 8.860

7.  Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.

Authors:  M M Ho-dac-Pannekeet; J K Hiralall; D G Struijk; R T Krediet
Journal:  Adv Perit Dial       Date:  1997

8.  Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.

Authors:  Mariska L M Lieuw-A-Fa; Victor W M van Hinsbergh; Tom Teerlink; Rob Barto; Jos Twisk; Coen D A Stehouwer; Casper G Schalkwijk
Journal:  Nephrol Dial Transplant       Date:  2004-03       Impact factor: 5.992

Review 9.  The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.

Authors:  Yeoungjee Cho; David W Johnson; Sunil V Badve; Jonathan C Craig; Giovanni F M Strippoli; Kathryn J Wiggins
Journal:  Kidney Int       Date:  2013-05-22       Impact factor: 10.612

10.  Glycoxidation and inflammation in renal failure patients.

Authors:  Melpomeni Peppa; Jaime Uribarri; Weijing Cai; Min Lu; Helen Vlassara
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860
View more
  2 in total

1.  A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy.

Authors:  Masaaki Nakayama; Yoshindo Kawaguchi; Takashi Akiba; Masao Kim; Hidemune Naito; Shigeko Hara; Teruhiko Maeba; Noriaki Yorioka; James A Sloand; Mark R Marshall
Journal:  Clin Exp Nephrol       Date:  2016-10-25       Impact factor: 2.801

2.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.